Translate page

This independent educational resource was provided over the last couple of months as a special service by the iCMLf in partnership with Springer Healthcare IME and is supported by a grant from Novartis Oncology.

Stories are based on articles published in international peer-reviewed journals, or conference sessions and written by highly experienced and knowledgeable writers. 

You can access the   CML stories from previous months here

Clinical reality in CML is in constant change. Thanks to the hard work and progress of clinicians and researchers worldwide, interesting updates on CML science, diagnostics, treatment and care are regularly presented at international meetings and published in leading peer-reviewed journals.

This section provides you with a selection of scientific publications on CML, relevant news from scientific meetings and expert opinions from leaders in the field. You will also find links to active CML clinical trials.

21st Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
12-15 September, 2019 - Bordeaux, France

24th Congress of the European Hematology Association (EHA)
13-16 June, 2019 - Amsterdam, The Netherlands

Log-in on the EHA Learning Center platform with your EHA login details or create a free account and view CML related

60th Annual Meeting of the American Society of Hematology (ASH)
1-4 December, 2018 - San Diego, USA

Please find below a selection of interesting articles on CML from peer-reviewed journals. Recent publications include:

Clinical Publications:   

Scientific publications:

  • Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells
    (Tanaka Y et al. Exp Hematol, September 2020)
  • Checkpoint kinase-1 inhibitors and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologenous recombination DNA damage repair
    (Fan Z et al. Oncol Rep, September 2020) (epub ahead of print) - open access publication
  • A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor chronic myeloid leukemia cells
    (He B et al. Biomed Pharmacother, September 2020) – open access publication

Click here to see summaries of key CML publications provided to you as a special service by the iCMLf in partnership with Springer Healthcare IME

Search here for CML clinical trials: